No results for ‘’
Medi Caps Ltd
₹26.75
(3.25%)
Thu, 25 Jun 2026, 00:04 am
Health Technology
Pharmaceuticals: Major
24.5KMedi Caps PB Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 4.02 | 2.14 | 1.44 | 2.05 | 6 | 6.46 | 10.66 | 0 | 0 | 0 | 29.64 | 25.09 | 25.05 | 3.83 | 0 | 4.52 | 6.14 | 24.81 | 0 | 0 |
| Price to book ratio | 0.84 | 0.46 | 0.40 | 0.14 | 0.38 | 0.29 | 0.18 | 0.22 | 0.16 | 0.21 | 0.31 | 0.39 | 0.32 | 0.22 | 0.11 | 0.48 | 0.53 | 0.37 | 0.46 | 0.43 |
| Price to sales ratio | 1.45 | 0.96 | 1.12 | 0.36 | 1.06 | 0.67 | 0.63 | 0.58 | 0.35 | 0.48 | 0.59 | 0.78 | 0.58 | 0.40 | 0.24 | 0.88 | 0.91 | 0.88 | 2.03 | 2.04 |
| Price to cash flow ratio | 3.56 | 1.97 | 1.57 | 1.34 | 5.16 | 6.64 | 2.06 | 0 | 0 | 2.48 | 9.85 | 8.56 | 6.85 | 3.46 | 2.20 | 3.28 | 8.82 | 0 | 7.96 | 10.20 |
| Enterprise value | 24.77Cr | 16.4Cr | 16.8Cr | 6.95Cr | 21.24Cr | 16.66Cr | 3.21Cr | 14.75Cr | 12.38Cr | 25.35Cr | 21.53Cr | 25.97Cr | 17.43Cr | 5.98Cr | -9.52Cr | 17.21Cr | 25.2Cr | 7.32Cr | 19.65Cr | 17.55Cr |
| Enterprise value to EBITDA ratio | 7.68 | 3.99 | 4.52 | 1.59 | 5.86 | 3.29 | 0.80 | 3.82 | 3.34 | 0 | 8.19 | 15.98 | 8.06 | 1.25 | 0 | 1.57 | 2.91 | 1.37 | 0 | 0 |
| Debt to equity ratio | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0.08 | 0.11 | 0.13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on equity % | 0 | 24.16 | 31.54 | 6.79 | 6.50 | 4.64 | 2.06 | -0.85 | -1.60 | -2.50 | 1.06 | 1.60 | 1.28 | 5.80 | -6.27 | 11.49 | 9.09 | 1.59 | -1.87 | -0.47 |
Medi Caps Ltd Price to Book Ratio
The Medi Caps Ltd Price to Book Ratio is a key financial metric used by investors to evaluate Medi Caps Ltd's valuation, profitability, and overall financial performance. Tracking the Medi Caps Ltd Price to Book Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Medi Caps Ltd (NSE: MEDICAPS, BSE: 523144) is currently trading at ₹26.75, with a market capitalization of ₹34.39Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Medi Caps Ltd Price to Book Ratio is essential for fundamental analysis.
Medi Caps Ltd Price to Book Ratio Current Value
The current Medi Caps Ltd Price to Book Ratio stands at 0.43.
The Medi Caps Ltd Price to Book Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Medi Caps Ltd Price to Book Ratio Historical Trend
The Medi Caps Ltd Price to Book Ratio has shown the following historical trend:
- 2024: 0.43
- 2023: 0.46
- 2022: 0.37
- 2021: 0.53
- 2020: 0.48
The decline in Medi Caps Ltd Price to Book Ratio indicates improving financial efficiency or better earnings growth.
What Medi Caps Ltd Price to Book Ratio Indicates for Investors
The Medi Caps Ltd Price to Book Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/B ratio shows how the market values company assets relative to book value.
Medi Caps Ltd Price to Book Ratio Analysis Summary
The Medi Caps Ltd Price to Book Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Medi Caps Ltd Price to Book Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Medi Caps Ltd Price to Book Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.